GT Biopharma GTBP
NASDAQ GTBP
$6.10 -0.10 (-1.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Return on Assets [ROA] (2011 - 2026)

Updated

GT Biopharma (GTBP) recorded Return on Assets [ROA] of -146.32% in Q1 2026, up 228.52 percentage points from -374.83% a year earlier and up 51.62 percentage points from the prior quarter.

Analysis

GT Biopharma (GTBP) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, GT Biopharma reported Return on Assets [ROA] of -201.43%, down 49.18 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of +732.90 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -152.25% in FY2024 (-67.90 pp), -84.35% in FY2023 (+1.42 pp), -85.77% in FY2022 (+220.93 pp) and -306.70% in FY2021 (+627.62 pp).
  • The Q1 2026 figure is the highest quarterly Return on Assets [ROA] since Q1 2024.
  • On a year-over-year basis, Return on Assets [ROA] rose in two of the last four quarters, with an average year-over-year change of -38.41 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 4630.53 percentage points in Q2 2021, against a drop of 790.42 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -197.94% (Q4 2025), -182.18% (Q3 2025) and -216.46% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 GT Biopharma 8.73 Mn 8.73 Mn - -146.32%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -146.32%
Dec 31, 2025 -197.94%
Sep 30, 2025 -182.18%
Jun 30, 2025 -216.46%
Mar 31, 2025 -374.83%
Dec 31, 2024 -254.06%
Mar 31, 2024 -103.45%
Dec 31, 2023 -87.18%
Sep 30, 2023 -93.43%
Jun 30, 2023 -105.34%
Mar 31, 2023 -106.07%
Dec 31, 2022 -112.45%
Sep 30, 2022 -148.86%
Jun 30, 2022 -80.20%
Mar 31, 2022 -44.63%
Dec 31, 2021 -110.52%
Sep 30, 2021 3.20%
Jun 30, 2021 -8.35%
Mar 31, 2021 -33.80%
Dec 31, 2020 679.90%
API Access

GT Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY